N-terminal-pro brain natriuretic peptide levels in children with allergic rhinitis
dc.contributor.author | Artac, Hasibe | |
dc.contributor.author | Vatansev, Husamettin | |
dc.contributor.author | Cimen, Derya | |
dc.contributor.author | Arslan, Derya | |
dc.contributor.author | Kaya, Fatma | |
dc.contributor.author | Kayis, Seyit Ali | |
dc.contributor.author | Oran, Bulent | |
dc.date.accessioned | 2020-03-26T19:25:25Z | |
dc.date.available | 2020-03-26T19:25:25Z | |
dc.date.issued | 2016 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description.abstract | Background/aim: Persistent upper airway obstruction may lead to increased pulmonary arterial pressure (PAP). The aim of this study was to evaluate N-terminal pro brain natriuretic peptide (NT-proBNP) concentrations and PAP values in children with allergic rhinitis. Materials and methods: Sixty-six patients with allergic rhinitis and 22 healthy children were prospectively enrolled in this study. Plasma NT-proBNP levels were measured at first admission and after treatment. Simultaneously, echocardiography was done to assess pulmonary arterial hypertension, and rhinitis symptom scores were recorded. Results: The median age of the study group was 9.0 (5.0. 17.0) years; 26 were female. PAP was found to be normal in all the patients. There was a negative correlation between age and NT-proBNP levels (r = -0.452, P < 0.01). Nasal blockage levels affected NT-proBNP levels mildly (P = 0.067). No significant difference between before and after nasal steroid treatment was observed in NT-proBNP levels. Conclusion: These results suggest that NT-proBNP level and PAP may not be affected in children with allergic rhinitis, and primarily this influence may be associated with the severity of nasal obstruction. | en_US |
dc.identifier.doi | 10.3906/sag-1502-143 | en_US |
dc.identifier.endpage | 1134 | en_US |
dc.identifier.issn | 1300-0144 | en_US |
dc.identifier.issn | 1303-6165 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 27513415 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 1130 | en_US |
dc.identifier.uri | https://dx.doi.org/10.3906/sag-1502-143 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/33843 | |
dc.identifier.volume | 46 | en_US |
dc.identifier.wos | WOS:000378646700028 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | TR-Dizin | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | TUBITAK SCIENTIFIC & TECHNICAL RESEARCH COUNCIL TURKEY | en_US |
dc.relation.ispartof | TURKISH JOURNAL OF MEDICAL SCIENCES | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | Allergic rhinitis | en_US |
dc.subject | pulmonary arterial pressure | en_US |
dc.subject | N-terminal pro B-type natriuretic peptide | en_US |
dc.subject | nasal obstruction | en_US |
dc.subject | cardiac evaluation | en_US |
dc.title | N-terminal-pro brain natriuretic peptide levels in children with allergic rhinitis | en_US |
dc.type | Article | en_US |